[Fatal drug-induced Lyell syndrome in combined benoxaprofen-aurothioglucose therapy].
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006051:Aurothioglucose / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006046:Gold / Q000009:adverse effects*; D006801:Humans; D011422:Propionates / Q000009:adverse effects* / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000209:etiology*
D000893:Anti-Inflammatory Agents; D011422:Propionates; C011677:benoxaprofen; D006051:Aurothioglucose; D006046:Gold
Arznei-induziertes tödliches Lyell-Syndrom unter kombinierter Benoxaprofen-Aurothioglukose-Therapie.